Evidence map›Paper›PMID 30900312›Full record

ArticleThe Prostate2019

Dietary palmitate cooperates with Src kinase to promote prostate tumor progression.

Sungjin Kim, Xiangkun Yang, Amelia Yin, Junyi Zha, Zanna Beharry, Aiping Bai, Alicja Bielawska, Michael G Bartlett, Hang Yin, Houjian Cai

Open access · greenAbstract read
In one paragraph

Article in The Prostate, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Lipid Biochemistry and its Role in Human Diseases.Current medicinal chemistry · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Lipid Metabolism in Cancer Cells.Advances in experimental medicine and biology · 2021
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sungjin KimDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia.
Xiangkun YangDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia.
Amelia YinDepartment of Biochemistry and Molecular Biology, Center for Molecular Medicine, University of Georgia, Athens, Georgia.
Junyi ZhaDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia.
Zanna BeharryDepartment of Chemistry and Physics, Florida Gulf Coast University, Fort Myers, Florida.
Aiping BaiDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Alicja BielawskaDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Michael G BartlettDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia.
Hang YinDepartment of Biochemistry and Molecular Biology, Center for Molecular Medicine, University of Georgia, Athens, Georgia.
Houjian CaiDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia.ORCID 0000-0002-0158-1017
University of Georgia · USMedical University of South Carolina · USFlorida Gulf Coast University · US

Funding

Heparan Sulfate in Prostate CancerU01CA225784 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI CAI, HOUJIAN, WANG, LIANCHUN · 2018 to 2023
$2.6M
Targeting myristoylation of Src family kinases for inhibition of prostate tumorigenesisR01CA172495 · NCI · UNIVERSITY OF GEORGIA · PI CAI, HOUJIAN · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA172495NCI NIH HHS R01CA172495NCI NIH HHS U01 CA225784
6 · The paper itself

Abstract

Numerous genetic alterations have been identified during prostate cancer progression. The influence of environmental factors, particularly the diet, on the acceleration of tumor progression is largely unknown. Expression levels and/or activity of Src kinase are highly elevated in numerous cancers including advanced stages of prostate cancer. In this study, we demonstrate that high-fat diets (HFDs) promoted pathological transformation mediated by the synergy of Src and androgen receptor in vivo. Additionally, a diet high in saturated fat significantly enhanced proliferation of Src-mediated xenograft tumors in comparison with a diet high in unsaturated fat. The saturated fatty acid palmitate, a major constituent in a HFD, significantly upregulated the biosynthesis of palmitoyl-CoA in cancer cells in vitro and in xenograft tumors in vivo. The exogenous palmitate enhanced Src-dependent mitochondrial β-oxidation. Additionally, it elevated the amount of C16-ceramide and total saturated ceramides, increased the level of Src kinase localized in the cell membrane, and Src-mediated downstream signaling, such as the activation of mitogen-activated protein kinase and focal adhesion kinase. Our results uncover how the metabolism of dietary palmitate cooperates with elevated Src kinase in the acceleration of prostate tumor progression.

Indexed as

AnimalsCell Line, TumorCell Transformation, NeoplasticDiet, High-FatDisease ProgressionHEK293 CellsHeterograftsHumansMaleMiceMice, Inbred C57BLMice, SCIDPalmitatesPC-3 CellsProstatic Neoplasmssrc-Family KinasesPalmitatessrc-Family Kinasespalmitate/fatty acid metabolism/Src kinase/prostate cancer

Identifiers

PMID30900312
PMCPMC6502658
OpenAlexW2923760766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.